TH-17 cells in the circle of immunity and autoimmunity
By E. Bettelli, M. Oukka, V. Kuchroo. Nature Immunology, 2007
1,321 citations recorded by the source corpus.
Subfields: Immunology
View Paper: https://www.semanticscholar.org/paper/28f0f08a5592283e0bf741523024d85a90a785fa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Prostate cancer and inflammation: the evidence (2012, background): “Th17 cells are thought to be the key mediators in a number of autoimmune diseases, and may play a role in inflammation-associated cancer.(98,99) The role of Th17 cells in cancer is currently a topic of significant debate, as there appear to be conflicting reports as to whether Th17 cells promote car”
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation (2008, background): “6 and S12), IL-6 may render responder T cells resistant to Treg suppression depending on the amount of IL-6 produced by DCs, and also facilitate the differentiation of naı̈ve T cells to Th17 cells (35, 36).”
- T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. (2008, background): “A novel TH subset, termed THIL-17, TH17 or inflammatory TH (THi), has been recently identified as a distinct TH lineage (Bettelli et al., 2007; Dong, 2006; Reiner, 2007; Weaver et al., 2006).”
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis (2010, background): “Recent insights into the TH17/IL-17 biology from these models have led to the hypothesis that the effects of TH17 cells and their signature cytokine IL-17A can more profoundly explain T cell–dependent pathobiology in these models, replacing the TH1 paradigm, in which TH1 cytokines are the paramount ”
- 1,25-dihydroxyvitamin D3 and interleukin-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3 (2009, background): “Recently, additional CD4 T cell lineages including IL-17-secreting T cells (Th17), regulatory T cells (Tregs),(3) and T follicular helper cells (TFH) have been identified, which arise in response to T cell activation under appropriate conditions (2, 3).”
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression (2010, background): “In addition, TGF-β, together with IL-6, induces Th-17 cells [25,32,33].”